What You Should Know:
– StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that it has acquired Maynard, Mass.-based EmpiraMed Inc., a digital health technology leader in the field of virtual clinical studies for real-world evidence.
– EmpiraMed performs post-market, prospective, virtual clinical studies to generate real-world evidence for life sciences, pioneering site-less virtual studies. Its software helps clients produce evidence for expanding market access, deploy patient-centered rare disease registries, and support faster regulatory approval of new indications and label extensions.
EmpiraMed and StoryCatch Partners: Advancing Real-World Evidence and Mental Wellbeing Through Integration
EmpiraMed, a digital health technology leader specializing in decentralized clinical trials (DCTs) and real-world evidence (RWE) generation, has merged with StoryCatch Partners, an organization dedicated to improving global mental wellbeing through empathy-driven solutions and high-accuracy health data. Together, they aim to enhance understanding and care for complex participant populations by integrating innovative digital platforms and evidence-based approaches.
- EmpiraMed’s Expertise:
Operating as a digital Contract Research Organization (CRO), EmpiraMed conducts post-market virtual clinical studies that generate RWE for the life sciences sector. The company sits at the intersection of DCT and RWE, delivering scalable, prospective solutions to optimize healthcare outcomes. - StoryCatch Partners’ Mission:
With a commitment to enhancing global mental, emotional, and physical health, StoryCatch Partners builds scalable, interoperable companies. It leverages:- Empathy-driven storytelling to foster peer connections and stakeholder engagement.
- High-accuracy health data to provide actionable insights for improved wellbeing.
This approach integrates clarity, empathy, and evidence to drive meaningful change in healthcare.
- Integration Highlights:
- The merger retains EmpiraMed’s team and existing solutions while incorporating StoryCatch’s expertise in storytelling and mental health engagement.
- James Cavan, a seasoned industry professional, will lead EmpiraMed during the transition.
- Samantha Trotman Burman, CEO of StoryCatch Partners and founder of the Isleworth Group, continues as CEO of the combined entity. Her leadership experience includes roles at Bain Capital and Parthenon Capital.
By combining EmpiraMed’s digital health capabilities with StoryCatch’s empathetic and evidence-based framework, the partnership is poised to address complex health challenges and redefine care for diverse participant populations.
“EmpiraMed was the first company to run site-less studies while leading the way in engaging patients to self-report data,” said Keith Parent, founder of EmpiraMed. “StoryCatch Partners’ vision to improve total health with evidence and understanding aligns with our commitment to gain real-world evidence simpler, faster and more cost effectively than traditional methods. Joining StoryCatch Partners will help us deliver the best value to our clients and team.”
